Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enovix Corporation (ENVX) vs Tilray Brands Inc (TLRY) Price & Performance

Enovix CorporationTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Enovix Corporation vs Tilray Brands Inc — how do they compare? Enovix Corporation trades at $4.59 (market cap $1.11B), while Tilray Brands Inc trades at $4.35 (market cap $541.36M). The key difference: Enovix Corporation is far larger — about 2.1× Tilray Brands Inc's market cap. Which is the better fit depends on your goals.

ENVXTLRY
Market Cap
$1.11B$541.36M
Sector
TechnologyHealth
52-Week High
$15.93$21.00
52-Week Low
$4.84$4.31
Enterprise Value
$1.13B$638.50M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enovix Corporation

ENVX is trading at $4.59, down 9.29% in the last session, with a bearish technical signal. The company shows consistent quarterly earnings beats but remains deeply unprofitable with a -499.64% net income margin. Recent positive developments include the appointment of a former Apple operations leader as COO and progress in commercial battery production for smart eyewear and smartphone markets.

Despite analyst optimism (75% buy ratings, $12.75 consensus target), ENVX faces significant execution risks as it scales production. The stock offers speculative growth potential in advanced battery technology but requires substantial revenue acceleration to justify current valuations amid persistent cash burn and negative profitability.

Tilray Brands Inc

TLRY trades at $4.36, down 0.57% on the day, amid a bearish technical signal and mixed quarterly earnings. The company reported a net loss of -$2.19 billion for 2025 despite revenue growth to $821 million, with a negative net income margin of -156.67%. Recent developments include medical cannabis expansion in Panama and the acquisition of HelloMD to enhance digital healthcare capabilities.

While low valuation ratios (P/S of 0.55, P/B of 0.35) suggest potential undervaluation, persistent losses and negative cash flow from operations pose significant risks. Analyst sentiment is cautious with a 'Hold' consensus, reflecting concerns over profitability despite growth initiatives. The stock's outlook hinges on achieving sustainable profitability and navigating competitive and regulatory pressures.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Enovix Corporation

Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.

Read more on ENVX

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY